New antiviral pill halves risk of COVID-19 hospitalization, Merck says
newsdepo.com
Merck announced promising trial results this week, but the full data has yet to be released.New antiviral pill halves risk of COVID-19 hospitalization, Merck says
Merck announced promising trial results this week, but the full data has yet to be released. Read more

